These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27630207)

  • 1. Gas6 Promotes Oligodendrogenesis and Myelination in the Adult Central Nervous System and After Lysolecithin-Induced Demyelination.
    Goudarzi S; Rivera A; Butt AM; Hafizi S
    ASN Neuro; 2016 Oct; 8(5):. PubMed ID: 27630207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TAM receptor Tyro3 regulates myelination in the central nervous system.
    Akkermann R; Aprico A; Perera AA; Bujalka H; Cole AE; Xiao J; Field J; Kilpatrick TJ; Binder MD
    Glia; 2017 Apr; 65(4):581-591. PubMed ID: 28145605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.
    Ray AK; DuBois JC; Gruber RC; Guzik HM; Gulinello ME; Perumal G; Raine C; Kozakiewicz L; Williamson J; Shafit-Zagardo B
    Glia; 2017 Dec; 65(12):2051-2069. PubMed ID: 28925029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
    Binder MD; Cate HS; Prieto AL; Kemper D; Butzkueven H; Gresle MM; Cipriani T; Jokubaitis VG; Carmeliet P; Kilpatrick TJ
    J Neurosci; 2008 May; 28(20):5195-206. PubMed ID: 18480276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effect of GAS6 in remyelination is dependent upon Tyro3.
    Asadian N; Aprico A; Chen M; Yuen D; Johnston APR; Kilpatrick TJ; Binder MD
    Glia; 2024 Aug; 72(8):1392-1401. PubMed ID: 38572807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.
    Binder MD; Xiao J; Kemper D; Ma GZ; Murray SS; Kilpatrick TJ
    PLoS One; 2011 Mar; 6(3):e17727. PubMed ID: 21423702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
    Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
    Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas6 Induces Myelination through Anti-Inflammatory IL-10 and TGF-β Upregulation in White Matter and Glia.
    Goudarzi S; Gilchrist SE; Hafizi S
    Cells; 2020 Jul; 9(8):. PubMed ID: 32722558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and mer in the developing rat central nervous system.
    Prieto AL; Weber JL; Lai C
    J Comp Neurol; 2000 Sep; 425(2):295-314. PubMed ID: 10954847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
    Ou Z; Sun Y; Lin L; You N; Liu X; Li H; Ma Y; Cao L; Han Y; Liu M; Deng Y; Yao L; Lu QR; Chen Y
    J Neurosci; 2016 Oct; 36(41):10560-10573. PubMed ID: 27733608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
    Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
    Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis.
    Weinger JG; Brosnan CF; Loudig O; Goldberg MF; Macian F; Arnett HA; Prieto AL; Tsiperson V; Shafit-Zagardo B
    J Neuroinflammation; 2011 May; 8():49. PubMed ID: 21569627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system.
    Blades F; Aprico A; Akkermann R; Ellis S; Binder MD; Kilpatrick TJ
    Glia; 2018 Oct; 66(10):2209-2220. PubMed ID: 30208252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
    Shafit-Zagardo B; Gruber RC; DuBois JC
    Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gas6/TAM System and Multiple Sclerosis.
    Bellan M; Pirisi M; Sainaghi PP
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
    Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
    PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
    Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
    J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
    Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
    Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.